• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 3. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 4. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

Latest Research Insights on 3-[(4-fluorophenoxy)methyl]-4-methoxybenzaldehyde (CAS: 329222-88-0) in Chemical Biology and Pharmaceutical Applications

The compound 3-[(4-fluorophenoxy)methyl]-4-methoxybenzaldehyde (CAS: 329222-88-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and relevance in drug discovery.

Recent studies have highlighted the role of 3-[(4-fluorophenoxy)methyl]-4-methoxybenzaldehyde as a key intermediate in the synthesis of novel bioactive molecules. Its structural features, including the fluorophenoxy and methoxybenzaldehyde moieties, make it a versatile scaffold for designing compounds with enhanced pharmacological properties. Researchers have explored its utility in the development of enzyme inhibitors, receptor modulators, and antimicrobial agents.

One of the most notable advancements involves the application of this compound in the synthesis of small-molecule inhibitors targeting specific kinases involved in cancer progression. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 3-[(4-fluorophenoxy)methyl]-4-methoxybenzaldehyde exhibited potent inhibitory activity against certain oncogenic kinases, with IC50 values in the nanomolar range. These findings suggest its potential as a lead compound for anticancer drug development.

In addition to its role in oncology, recent research has explored the antimicrobial properties of 3-[(4-fluorophenoxy)methyl]-4-methoxybenzaldehyde. A study in Bioorganic & Medicinal Chemistry Letters reported that this compound and its analogs displayed significant activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The mechanism of action appears to involve disruption of bacterial cell membrane integrity, making it a promising candidate for addressing antibiotic resistance.

From a synthetic chemistry perspective, advancements have been made in optimizing the production of 3-[(4-fluorophenoxy)methyl]-4-methoxybenzaldehyde. A 2022 paper in Organic Process Research & Development detailed a scalable and cost-effective synthesis route, achieving high yields and purity. This progress is critical for facilitating further research and potential industrial applications of the compound.

Despite these promising developments, challenges remain in fully elucidating the pharmacokinetic and toxicological profiles of 3-[(4-fluorophenoxy)methyl]-4-methoxybenzaldehyde. Ongoing studies are investigating its metabolic stability, bioavailability, and safety in preclinical models. These efforts are essential for translating the compound's potential into clinically viable therapeutics.

In conclusion, 3-[(4-fluorophenoxy)methyl]-4-methoxybenzaldehyde (CAS: 329222-88-0) represents a compound of growing importance in chemical biology and pharmaceutical research. Its diverse applications, from kinase inhibition to antimicrobial activity, underscore its versatility as a molecular scaffold. Continued research and development efforts are expected to further unlock its therapeutic potential and address current limitations in drug discovery.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)